Jayastu Senapati (@jayastumd) 's Twitter Profile
Jayastu Senapati

@jayastumd

Asst. Professor, Dept. of Leukemia,
MD Anderson Cancer Center Houston
(CMC Vellore & AIIMS ND alumnus). Tweets are my own.
Vasudhaiva Kutumbakam 🇮🇳🌍🇺🇸

ID: 1974184626

linkhttps://faculty.mdanderson.org/profiles/jayastu_senapati.html calendar_today20-10-2013 07:28:43

1,1K Tweet

2,2K Followers

573 Following

Jayastu Senapati (@jayastumd) 's Twitter Profile Photo

➡️ Check out our paper on Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms Haematologica haematologica.org/haematologica/… ✅ A clinically relevant and easy to use TP53 aberration burden stratification and a closer look at outcomes

➡️ Check out our paper on Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms <a href="/Haematologica/">Haematologica</a> 
haematologica.org/haematologica/…
✅ A clinically relevant and easy to use TP53 aberration burden stratification and a closer look at outcomes
Sanam Loghavi, MD صنم لغوی 🔬🧬 (@sanamloghavi) 's Twitter Profile Photo

New 📄🚨on everyone's least favorite myeloid neoplasms:TP53m AML&MDS 🧵In short: 🔴pls don’t exclude these pts of allo-HSCT, their only chance at cure.   🔴TP53 burden is key 🔴Blasts matter (for real… not only b/c I’m a pathologist 🔬😉) haematologica.org/article/view/1…

New 📄🚨on everyone's least favorite myeloid neoplasms:TP53m AML&amp;MDS 🧵In short:
🔴pls don’t exclude these pts of allo-HSCT, their only chance at cure.  
🔴TP53 burden is key
🔴Blasts matter (for real… not only b/c I’m a pathologist 🔬😉)
haematologica.org/article/view/1…
Jayastu Senapati (@jayastumd) 's Twitter Profile Photo

➡️ Excited to share the phase 1b/2 clin trial of Aza-Ven-Magro in ND high-risk & R/R AML from MD Anderson Cancer Center led by Naval Daver, M.D., just out in Clinical Cancer Research ✅ Interesting correlative analysis by Hussein Abbas interrogating mech of Magro resistance in TP53-mut AML ✅Despite

➡️ Excited to share the phase 1b/2 clin trial of Aza-Ven-Magro in ND high-risk &amp; R/R AML from <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> led by <a href="/Daver_Leukemia/">Naval Daver, M.D.</a>, just out in <a href="/CCR_AACR/">Clinical Cancer Research</a> 
✅ Interesting correlative analysis by <a href="/HusseinAbbasLab/">Hussein Abbas</a> interrogating mech of Magro resistance in TP53-mut AML
✅Despite
Jayastu Senapati (@jayastumd) 's Twitter Profile Photo

✈️ After a long time Flew Air India 🔃Kolkata to New Delhi. Nice retrofitted aircraft upholstery, on time departure, courteous staff and really good meals! Top notch. Happy to have flown in the New Air India. Now time for better international connectivity from Kolkata Airport